Blood pressure monitor put to the test in validation study
NCT ID NCT06980766
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested how accurately the Philips EarlyVue VS30 monitor measures blood pressure compared to a standard manual cuff. Researchers enrolled 99 people aged 3 to 85. The goal was to see if the device meets international accuracy standards for both adults and children.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Philips EarlyVue VS30 monitor
- What this could lead to
- If successful, this could confirm that the monitor provides accurate blood pressure readings for a wide age range, supporting its use in clinical settings.
- What could go wrong
- This is a validation study, not a treatment trial. It only checks accuracy against a standard device and does not test any new therapy or health outcome.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
99 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Mar 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Healthy volunteers, both male and females aged 3-85. Minimum of 35 participants aged 3-12 and a minimum of 50 participants aged \>12-85
- Ages
-
3 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants must be able to provide an informed consent or have legally authorized representative consent to participate. * Participants that are between 7 and 17 years of age must provide assent to participate in the study. * Participant must be willing and able to comply with the study procedures. * Participant or legally authorized representative must be able to read or write in English. * Participant must be 3 to 85 years of age. * Participants must have an arm circumference in the range of 14-45 centimeters. Exclusion Criteria: * Participant is unwilling to provide informed consent. * Participants with deformities or abnormalities that may prevent proper application of the device under test. * Participants whose upper arm circumference is less than 14 cm or greater than 45 cm. * Female participants who are self-reported as pregnant, or who are self-reported as trying to get pregnant. * Participants with known heart arrhythmias. * Participants with peripheral vascular disease. * Participants with clotting disorders. * History of bleeding disorders or personal history of prolonged bleeding from injury * History of blood clots * Hemophilia * Participants that cannot tolerate sitting for up to 1 hour. * Participant with a blood pressure demographic that has already been filled. * Other known health conditions that will prevent safe participation in the study upon disclosure in health assessment form or verbally. * Participant is evaluated by the investigator or clinician and found to be medically unsuitable for participation in this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non invasive blood pressure are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Element Materials Technology
Louisville, Colorado, 80027, United States